Halitosis Algorithm · Reasoning GP

Done

Safety

Red Flags — Screen for Serious Underlying Pathology

Halitosis is benign in 90% of cases but can signal oropharyngeal cancer, lung abscess, or severe metabolic disease — exclude before treating empirically.

Oropharyngeal / oral cancer Persistent unilateral halitosis + non-healing ulcer, neck lump, dysphagia, trismus, unexplained weight loss → 2WW head & neck cancer

Lung abscess / bronchiectasis Foul, sweet, or faeculent breath + chronic productive cough, haemoptysis, fever, weight loss → Urgent CXR + same-day respiratory review

Oesophageal pathology Regurgitation of undigested food (Zenker's diverticulum), severe dysphagia, progressive difficulty swallowing → 2WW upper GI endoscopy

Diabetic ketoacidosis (DKA) Fruity/ketotic breath + nausea, vomiting, Kussmaul breathing, confusion, known/undiagnosed diabetes → 999

Uraemic fetor Fishy/ammonia breath + uraemic symptoms (fatigue, itching, oedema), known CKD or risk factors → Urgent U&E + same-day nephrology if acutely unwell

Hepatic fetor Musty/sweet "fetor hepaticus" + jaundice, confusion, bleeding tendency, known liver disease → Same-day ED if encephalopathy

Nasal foreign body (child) Unilateral foul-smelling nasal discharge in child → Same-day ENT or ED (child) for removal

Pseudohalitosis / halitophobia Patient convinced of halitosis despite others not noticing, significant distress, social withdrawal → Screen for OCD / dysmorphophobia — consider IAPT referral

Head and neck cancers have 5-year survival of 50–60% overall but >80% if caught at stage I–II — the 2WW pathway exists precisely to capture these patients. Lung abscess and bronchiectasis are associated with characteristic halitosis (volatile sulfur compounds + anaerobic bacteria) that is qualitatively distinct from oral halitosis. DKA and hepatic encephalopathy are life-threatening metabolic emergencies presenting with pathognomonic breath odours. Nasal foreign bodies in children are commonly missed and cause significant morbidity from chronic infection.

Done

Diagnose

History — Characterise the Halitosis & Identify Source

90% of halitosis originates in the mouth or posterior tongue — identify oral vs extraoral source with targeted history.

Duration & onset

Acute → infection (tonsillitis, abscess, sinusitis), DKA. Chronic (>3 months) → gum disease, tongue coating, chronic rhinosinusitis, GI pathology.

Quality of odour

Rotting/sulphurous → periodontal / tongue coating (VSC). Fruity/sweet → DKA (ketones). Faeculent → anaerobic lung infection, GI. Fishy/ammonia → uraemia. Musty → hepatic fetor.

Oral hygiene

Brushing frequency, flossing, tongue brushing, dental attendance, denture care, orthodontic appliances. Last dental visit? Bleeding gums?

ENT symptoms

Postnasal drip, chronic nasal congestion, nasal polyps, recurrent sinusitis → posterior nasal/sinus source (15% of halitosis). Mouth breathing worsens oral halitosis.

GI symptoms

Heartburn, regurgitation, dysphagia → GORD, Zenker's diverticulum, H. pylori. Note: GORD causes halitosis in minority despite common patient belief.

Medications

Xerostomia-causing drugs → halitosis (tricyclics, antihistamines, diuretics, ACE inhibitors, antipsychotics). Also: metronidazole (metallic taste), disulfiram, dimethyl sulfoxide.

Social history

Smoking (worsens VSC production), alcohol (dehydrates oral mucosa + acetaldehyde), dietary factors (garlic, onions, cruciferous vegetables — transient halitosis).

Impact on life

Assess social functioning, relationship impact, anxiety level. Screen for halitophobia — does anyone else notice it? Has a professional confirmed it?

Studies using organoleptic assessment (clinician smell rating) and gas chromatography show that 85–90% of halitosis originates intraorally — primarily volatile sulfur compounds (VSCs: hydrogen sulfide, methyl mercaptan) produced by anaerobic gram-negative bacteria on the tongue dorsum and in periodontal pockets. The quality of breath odour is a reliable pointer to the underlying cause and should be actively assessed in the consultation.

Done

Diagnose

Classification — Identify the Aetiology

Classify by anatomical origin to direct appropriate referral and treatment.

Genuine oral halitosis (85–90%)

Tongue coating (most common), periodontal disease, caries, poorly fitting dentures, dry mouth (xerostomia), oral infections. Primary VSC producers. Dentist-led management

Physiological halitosis

Morning breath (reduced saliva flow overnight), dietary (garlic, onions, spices), fasting state (ketones), smoking. Benign, temporary. No treatment beyond hygiene. Lifestyle advice

ENT-origin (10–15%)

Chronic rhinosinusitis, nasal polyps, postnasal drip, tonsil crypts (tonsilloliths), peritonsillar abscess, nasopharyngeal pathology. ENT referral if refractory

Respiratory origin

Bronchiectasis, lung abscess, empyema, active TB. Characteristic faeculent/sweet odour. Rare but important. Confirm with CXR. Respiratory referral

GI origin (rare)

GORD (controversial link), Zenker's diverticulum (undigested food regurgitation), H. pylori (weak evidence for direct halitosis). GI referral if symptomatic

Metabolic / systemic

DKA (fruity), uraemia (fishy/ammonia), hepatic failure (musty fetor hepaticus), trimethylaminuria (TMAU – fishy odour, fish-and-chip smell). Urgent if DKA/renal failure

Pseudohalitosis

Patient conviction not confirmed by objective assessment (organoleptic or instrument measurement). No true malodour. 5% of halitosis clinic patients. Reassurance + CBT/IAPT

Halitophobia

Persistent delusional belief despite reassurance, socially impairing. Part of OCD/somatic symptom disorder spectrum. Mental health input required. IAPT / psychiatry referral

Classification prevents unnecessary GI investigation — most patients believe their halitosis is GI in origin, but GORD is responsible for <1% of cases. Directing patients with genuine oral halitosis to dentistry is more effective than prescribing mouthwashes in primary care. Tonsilloliths are a frequently overlooked cause — patients often self-remove these, and ENT tonsillectomy is curative in refractory cases. Trimethylaminuria (TMAU) is rare (prevalence ~1:20,000) but important to recognise, as it causes extreme social disability and requires specialist dietary management.

Done

Diagnose

Targeted Examination — Oral, ENT & Systemic

A structured examination takes 3–4 minutes and localises the source in most cases.

Organoleptic assessment

Ask patient to exhale through mouth (eyes open, lips parted) at 10 cm distance from examiner. Grade 0–5 (Rosenberg scale). Then compare nasal exhalation (pinch mouth closed) — nasal source if nasal worse.

Tongue inspection

Posterior tongue dorsum — thick white/yellow coating indicates highest VSC production. Use tongue depressor. Grade 0 (pink, clean) to 3 (thick coated). Most important exam finding.

Periodontal / dental

Bleeding on probing, gingival recession, obvious caries, abscess, food trapping sites, calculus. Note presence of prosthetics (dentures, implants, orthodontics).

Oral mucosa & salivary flow

Dry mucosa, sticky saliva, furrowed tongue → xerostomia. Assess salivary pooling under tongue. Frothy saliva = dehydration. Assess lips for mouth-breathing signs (dry, cracked).

Tonsils

Tonsil crypts with white debris (tonsilloliths), tonsillar hypertrophy, peritonsillar asymmetry, exudate. Tonsilloliths are VSC-producing bacterial deposits.

Nasal examination

Anterior rhinoscopy — polyps, septal deviation, mucopurulent discharge, foreign body (child). Postnasal drip visible on posterior pharynx (cobblestoning).

Systemic examination

Jaundice, uraemic skin changes (scratch marks), signs of DM (acanthosis nigricans). Respiratory: clubbing, crepitations. Lymphadenopathy (malignancy, HIV).

Mental state

If pseudohalitosis suspected — assess for health anxiety, OCD features, social phobia. PHQ-9 and GAD-7 if significant distress.

Organoleptic assessment (clinical smell rating) remains the gold standard for halitosis assessment — more accessible than gas chromatography (OralChroma), which is a research or specialist tool. Comparing oral vs nasal exhalation differentiates oral from nasal/sinus source with 85% accuracy. Tongue coating assessment is the single most useful examination finding — posterior tongue dorsum VSC production accounts for 60% of all halitosis cases and is directly treatable with tongue scraping and improved hygiene.

Done

Diagnose

Investigations — Targeted, Not Routine

Most halitosis requires no investigation. Investigate only if systemic/ENT/GI cause is suspected.

Blood glucose / HbA1c

Capillary blood glucose + HbA1c — if fruity breath, osmotic symptoms, acanthosis. DKA suspected → urgent BM + ketones + venous blood gas.

U&E / eGFR

U&E — if uraemic fetor suspected (fishy/ammonia odour). CKD history or risk factors. Urea >25 mmol/L causes symptomatic uraemic fetor.

LFTs / coagulation

LFTs, albumin, INR — if hepatic fetor (jaundice, encephalopathy features). Also: viral hepatitis serology, USS abdomen.

CXR

Chest X-ray — if respiratory origin suspected (bronchiectasis, lung abscess). Cavity, consolidation, bronchial thickening. Follow-up CT chest if CXR abnormal.

Nasal endoscopy

Flexible nasendoscopy — via ENT if chronic rhinosinusitis not responding to treatment, polyps, nasopharyngeal pathology suspected. Not a primary care test.

H. pylori test

13C-urea breath test — if patient has dyspepsia + halitosis concern. Evidence for H. pylori as direct halitosis cause is weak, but treat if breath test positive per NICE CKS.

TMAU testing

Urine trimethylamine levels — only if characteristic fishy odour, normal oral examination, no dietary explanation. Refer via metabolic medicine. Very rare.

Do NOT routinely order

Upper GI endoscopy for halitosis alone (no evidence base), salivary gland scans, LFTs in young patients without risk factors, MRI head for halitosis

Blanket investigation of halitosis is not evidence-based and leads to unnecessary patient anxiety and healthcare cost. The vast majority of patients (85–90%) have oral halitosis that requires dental referral, not blood tests. Investigation should be driven by the suspected systemic cause identified in the history and examination. NICE CKS does not recommend H. pylori testing as routine in halitosis — the evidence for H. pylori as a direct cause of halitosis is weak, though treating confirmed infection may improve symptoms in patients with dyspepsia.

Done

Refer

Referral Criteria — Dental, ENT, Gastro, Mental Health

999 / Same-day ED

Emergency DKA (fruity breath + ketones + acidosis), hepatic encephalopathy, acute airway compromise from peritonsillar abscess, nasal foreign body with airway compromise

2WW head & neck

2-week wait Non-healing oral ulcer >3 weeks, neck lump >3 weeks, unexplained unilateral ear pain with normal otoscopy, red/white oral patches (NG12)

2WW upper GI

2-week wait Progressive dysphagia, regurgitation of undigested food (Zenker's), unexplained weight loss + GI symptoms, age >55 + dyspepsia + alarm symptoms (NG12)

Dentist (urgent)

Within 1 week Dental abscess, acute periodontal infection, pain with swelling. Most patients with oral halitosis: refer for periodontal assessment and professional cleaning

ENT routine

Routine Chronic rhinosinusitis not responding to 12 weeks of treatment, tonsilloliths causing significant halitosis + recurrent tonsillitis, suspected nasal polyps, Zenker's diverticulum

Respiratory

Urgent Suspected lung abscess (CXR cavity), bronchiectasis confirmation (CT chest), haemoptysis investigation

Mental health / IAPT

Routine Pseudohalitosis confirmed (organoleptic assessment negative) with high anxiety. Halitophobia with social impairment. PHQ-9 >10 + GAD-7 >10. IAPT CBT or OCD pathway.

Primary care manage

Physiological halitosis (dietary/morning), mild-moderate oral halitosis before dental review, GORD (treat with PPI), H. pylori eradication, xerostomia management

Head and neck cancer is the 6th most common cancer globally, with oral cavity cancer having 5-year survival of >80% at stage I vs <40% at stage IV — early 2WW referral is essential. Zenker's diverticulum can cause severe aspiration pneumonia if undiagnosed — dysphagia with regurgitation of undigested food must not be dismissed as GORD. Halitophobia is a well-described psychiatric entity associated with OCD that responds to CBT; reassurance alone is insufficient and inappropriate in these patients.

Done

Treat

Treatment Pathway — Cause-Directed Management

Treat the identified cause. Most primary care treatment is lifestyle + dental referral ± antimicrobial mouthwash.

Oral halitosis (VSC)

Tongue scraping + dental hygiene

Daily tongue scraping (posterior dorsum) — reduces VSC 70%. Professional dental scaling + root planing. Chlorhexidine 0.2% mouthwash BD ×2 weeks (not long-term — stains teeth).

Xerostomia

Saliva substitutes

AS Saliva Orthana spray, Biotène gel, or BioXtra. Pilocarpine 5 mg TDS if Sjögren's (via rheumatology). Review xerogenic medications — switch if possible.

Chronic rhinosinusitis

Mometasone 50mcg nasal spray + saline irrigation

Mometasone 2 sprays each nostril OD × 12 weeks. Add saline nasal douche (Sterimar or NeilMed) BD. Short course doxycycline 100 mg OD ×7 days if acute exacerbation.

GORD-associated

Omeprazole 20 mg OD

Treat for 4–8 weeks. Review lifestyle (head of bed elevation, avoid late meals). If no improvement, halitosis is unlikely GORD-related — reassess source.

H. pylori confirmed

Triple therapy

Clarithromycin 500 mg BD + amoxicillin 1g BD + omeprazole 20 mg BD × 7 days. Confirm eradication 4 weeks post-treatment with urea breath test.

Tonsilloliths

Irrigation + ENT referral

Water flosser irrigation of crypts (self-directed). Chlorhexidine gargle. ENT for tonsillectomy if recurrent tonsillitis + significant halitosis. NHS NICE tonsillectomy criteria apply.

Mouthwash guidance (evidence-based choices)

1st choiceChlorhexidine 0.2% mouthwash — 10 ml BD after brushing, rinse 1 min. Maximum 2-week course (tooth staining, taste disruption with long-term use). Most effective anti-VSC agent.

2nd choiceCetylpyridinium chloride (CPC) mouthwash — Colgate Peroxyl, Listermint. Can use longer term. Reduces VSC 25–40%. OTC, no prescription needed.

3rd choiceZinc acetate / zinc chloride mouthwash — neutralises VSC chemically. Can combine with CPC. TheraBreath, CB12 — evidence-based OTC choices.

Daily mechanical tongue scraping reduces volatile sulfur compound levels by 70% — more effective than brushing teeth alone (which reduces VSC 45%). Chlorhexidine mouthwash has strong RCT evidence for reducing oral bacteria and VSC levels, but its use beyond 2 weeks causes dose-dependent tooth staining and taste disruption — it is not appropriate as long-term therapy. Zinc compounds work by converting volatile hydrogen sulfide into insoluble zinc sulfide — this is a complementary mechanism to antibacterial agents and explains the additive benefit of zinc-containing products.

Done

Lifestyle

Non-Pharmacological Interventions — The Foundation of Treatment

Tongue scraping Use plastic or stainless steel tongue scraper on posterior tongue dorsum after every brushing. 2× daily minimum. More effective than tongue brushing alone. Reduces VSC 70%.

Dental hygiene optimisation Brush teeth 2× daily with fluoride toothpaste, floss or interdental brush daily, dental check every 6–12 months. Treat all active caries and periodontal disease. Electric toothbrush preferred.

Hydration Minimum 1.5–2L water/day. Saliva flow is the natural mouth cleanser — dehydration reduces flow. Chew sugar-free (xylitol) gum to stimulate salivary flow. Avoid excessive caffeine and alcohol.

Smoking cessation Smoking directly increases VSC levels, causes gum disease, and impairs immune response to oral bacteria. Refer to NHS Stop Smoking Service. Reduces halitosis within 2–4 weeks of stopping.

Dietary modification Avoid garlic, raw onions, spices (transient only — 24 hours). High-protein diets increase VSC. Increase green tea (catechins reduce VSC). Parsley has modest evidence for masking effect. Probiotic yoghurt reduces tongue coating VSC.

Alcohol reduction Alcohol dehydrates oral mucosa, reduces saliva flow, and acetaldehyde is itself a malodour. Target <14 units/week. Alcohol use disorder: AUDIT-C + FRAMES brief intervention if appropriate.

Denture care Remove dentures nightly, soak in Steradent/Milton, brush with soft toothbrush. Old/ill-fitting dentures harbour anaerobic bacteria. Dental review if dentures not replaced in >5 years.

Nasal breathing / mouth breathing Address nasal obstruction causing mouth breathing (mometasone spray, snoring assessment). Mouth breathing dramatically worsens oral halitosis through mucosal drying. Nasal dilator strips for night use.

Lifestyle interventions — particularly tongue scraping, optimal oral hygiene, and hydration — are the most effective long-term treatment for oral halitosis. Unlike mouthwashes, they address the cause (bacterial load on tongue + periodontal deposits) rather than temporarily masking symptoms. Smoking cessation is the single most impactful modifiable risk factor for both halitosis and periodontal disease — the two are deeply linked. Probiotic Lactobacillus salivarius WB21 has RCT evidence for reducing tongue coating VSC, though this is not yet standard care in the UK.

Done

Safety

Follow-Up, Monitoring & Safety-Netting

4–6 weeks

Review if GORD treatment started (reassess whether symptoms/halitosis improved — if not, GI source less likely). Review mouthwash use — switch from chlorhexidine to CPC at 2 weeks. Confirm dental referral attended.

8–12 weeks

Review rhinosinusitis treatment response (mometasone + irrigation). H. pylori eradication breath test at 4 weeks post-treatment. Pseudohalitosis — reassess anxiety/OCD symptoms with GAD-7.

3–6 months

Review chronic conditions associated with halitosis (DM glycaemia, CKD progression, Sjögren's). Mental health follow-up if halitophobia — has IAPT engagement occurred?

Safety-net same-day GP

New oral ulceration, neck swelling, progressive dysphagia — re-examine for head and neck cancer signs. Ketotic breath + vomiting + confusion → ED immediately.

Re-refer if

Dental treatment completed but halitosis persists → ENT assessment. Psychiatric symptoms escalating → increase support. New constitutional symptoms (weight loss, night sweats) → 2WW cancer referral.

Monitoring — xerostomia Rx

Pilocarpine LFTs + HR monitoring if used. Review all xerogenic medications annually — can any be stopped/reduced/switched? Annual dental review minimum.

Patient resources

British Dental Association (bda.org), NHS Choices oral hygiene guidance, Halitosis UK charity (patient information). Reassure: halitosis is common and treatable — do not minimise the significant social impact.

Persistent halitosis after adequate oral hygiene optimisation and dental treatment always warrants reassessment of the diagnosis. Up to 10% of cases labelled as "refractory oral halitosis" will have a genuine ENT cause (tonsilloliths, chronic sinusitis) that was initially missed. Failure to confirm H. pylori eradication leads to antibiotic resistance and reinfection. The psychological impact of halitosis is significant — studies show 40% of halitosis patients experience anxiety and social phobia; validating this and offering IAPT referral is part of holistic management.